Exane Derivatives’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,472	Closed	-$230K	–	998
2020 Q4	$230K	Buy	1,472 +306	+26%	+$39.3K	0.07%	292
2020 Q3	$133K	Sell	1,166 -66	-5%	-$7.12K	0.04%	252
2020 Q2	$138K	Sell	1,232 -4,928	-80%	-$523K	0.04%	248
2020 Q1	$553K	Buy	6,160 +4,961	+414%	+$487K	0.19%	113
2019 Q4	$135K	Sell	1,199 -1,003	-46%	-$107K	0.03%	290
2019 Q3	$216K	Buy	2,202 +1,300	+144%	+$147K	0.04%	245
2019 Q2	$118K	Buy	+902	New	+$116K	0.02%	314
2019 Q1	–	Sell	-24	Closed	-$2.34K	–	725
2018 Q4	$2.34K	Hold	24	–	–	﹤0.01%	518
2018 Q3	$3.36K	Sell	24 -980	-98%	-$123K	﹤0.01%	472
2018 Q2	$125K	Sell	1,004 -151	-13%	-$17.6K	0.03%	307
2018 Q1	$127K	Buy	1,155 +736	+176%	+$88K	0.03%	273
2017 Q4	$50.1K	Buy	419 +137	+49%	+$16.7K	0.01%	337
2017 Q3	$39.6K	Buy	+282	New	+$38.3K	0.01%	324
2015 Q1	–	Sell	-254	Closed	-$47K	–	580
2014 Q4	$47K	Buy	+254	New	+$47.1K	0.01%	326